saxitoxinol: reduced form of saxitoxin; used to study the metabolism of paralytic shellfish poisoning (PSP) in mammals [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 101712120 |
MeSH ID | M0221936 |
Synonym |
---|
saxitoxinol |
75420-34-7 |
3p2yeh7qbv , |
dihydrosaxitoxin |
alpha-saxitoxinol |
1h,8h-pyrrolo(1,2-c)purine-4-methanol, 2,6-diamino-3a,4,9,10-tetrahydro-10-hydroxy-, 4-carbamate, (3as,4r,10r,10as)- |
.alpha.-dihydrosaxitoxin |
.alpha.-saxitoxinol |
((3as,4r,10r,10as)-2,6-diamino-10-hydroxy-1,3a,4,8,9,10-hexahydropyrrolo(1,2-c)purin-4-yl)methyl carbamate |
1h,8h-pyrrolo(1,2-c)purine-4-methanol, 2,6-diamino-3a,4,9,10-tetrahydro-10-hydroxy-, .alpha.-carbamate, (3as-(3a.alpha.,4.alpha.,10.beta.,10ar*))- |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |